RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.6000
+0.0190 (3.27%)
Aug 11, 2026, 4:00 PM EDT - Market closed
RedHill Biopharma Market Cap
RedHill Biopharma has a market cap or net worth of $3.65 million as of August 11, 2026. Its market cap has increased by 128.03% in one year.
Market Cap
3.65M
Enterprise Value
747.55K
1-Year Change
128.03%
Ranking
Category
Stock Price
$0.60
ChartMarket Cap Chart
Since January 7, 2013, RedHill Biopharma's market cap has decreased from $58.80M to $3.65M, a decrease of -93.79%. That is a compound annual growth rate of -18.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 3.10M | 29.17% |
| Dec 31, 2025 | 2.40M | -69.62% |
| Dec 31, 2024 | 7.90M | 68.09% |
| Dec 29, 2023 | 4.70M | -47.78% |
| Dec 30, 2022 | 9.00M | -92.54% |
| Dec 31, 2021 | 120.70M | -57.65% |
| Dec 31, 2020 | 285.00M | 65.51% |
| Dec 31, 2019 | 172.20M | 45.81% |
| Dec 31, 2018 | 118.10M | 34.66% |
| Dec 29, 2017 | 87.70M | -34.06% |
| Dec 30, 2016 | 133.00M | 17.49% |
| Dec 31, 2015 | 113.20M | 31.93% |
| Dec 31, 2014 | 85.80M | 37.28% |
| Dec 31, 2013 | 62.50M | 6.29% |
| Jan 7, 2013 | 58.80M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apimeds Pharmaceuticals US | 6.40M |
| InMed Pharmaceuticals | 6.29M |
| Gelteq | 6.24M |
| Sonoma Pharmaceuticals | 6.17M |
| cbdMD | 5.94M |
| Universe Pharmaceuticals INC | 4.62M |
| Akanda | 3.94M |
| PRF Technologies | 3.19M |